Maculopapular Eruption After Omalizumab: Case Report Sheds Light on Rare Adverse Event Medha Baranwal29 May 2025 9:45 PM ISTSaudi Arabia: In a noteworthy case published in AME Case Reports, researchers have documented a rare pityriasis rosea-like skin eruption following the...
Omalizumab treats multi-food allergy better than oral immunotherapy, unravels study Dr. Kamal Kant Kohli10 March 2025 7:15 AM ISTA clinical trial has found that the medication omalizumab, marketed as Xolair, treated multi-food allergy more effectively than oral immunotherapy...
Medical Bulletin 05/ March/ 2025 Dr. Garima Soni5 March 2025 3:00 PM ISTHere are the top medical news for the day:Misdiagnosed Chronic Diseases can lead to long-Term Harm to Physical and Mental Health, Study revealsA...
Omalizumab Outshines Oral Immunotherapy in Multi-Food Allergy Treatment: Study Reveals Dr. Garima Soni5 March 2025 8:15 AM ISTA clinical trial has found that the medication omalizumab, marketed as Xolair, treated multi-food allergy more effectively than oral immunotherapy...
Aurobindo Pharma to Begin European Supply from China Facility in April Farhat Nasim17 Feb 2025 3:40 PM ISTNew Delhi: Aurobindo Pharma will commence supplies to Europe from its China facility from April onwards, according to Chief Financial Officer...
Effective therapy for chronic spontaneous urticaria may lower mortality: Study Jacinthlyn Sylvia27 Dec 2024 10:00 PM ISTA new study published in the Journal of Allergy and Clinical Immunology showed that effective therapy for chronic spontaneous urticaria (CSU) may...
Aurobindo Pharma arm announces successful Phase 1 clinical study outcome of their BP11 product Susmita Roy18 March 2024 1:30 PM ISTHyderabad: CuraTeQ Biologics Private Limited, a wholly owned subsidiary of Aurobindo Pharma Ltd, has announced that their Omalizumab biosimilar...
FDA approves first treatment for reactions to multiple foods after accidental exposure Dr. Kamal Kant Kohli19 Feb 2024 10:00 AM ISTThe FDA has approved omalizumab (Xolair) injection as first medication to help reduce allergic reactions to multiple foods after accidental exposure. ...
Roche Xolair gets USFDA nod for children, adults with one or more food allergies Ruchika Sharma17 Feb 2024 4:30 PM ISTIn the U.S., Genentech, a member of the Roche Group, and Novartis Pharmaceuticals Corporation work together to develop and co-promote Xolair.
Omalizumab Enhances Sleep and Health status in Chronic rhinosinusitis with nasal polyps Dr Riya Dave2 Feb 2024 10:15 PM ISTChronic rhinosinusitis with nasal polyps (CRSwNP) often leads to sleep disturbances, impacting patients' overall health. A recent study explores the...
Omalizumab better treatment option for managing chronic spontaneous urticaria during pregnancy Aditi25 Dec 2023 5:00 PM ISTTreating a pregnant patient with chronic spontaneous urticaria (CSU) can be quite challenging. According to recent findings, most CSU treatments for...
Roche Xolair gets USFDA priority review for children, adults with food allergies Ruchika Sharma20 Dec 2023 12:41 PM ISTBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) has accepted, under Priority Review, the company's supplemental...
